DV EQUITIES, LLC

Position in GRFS — Grifols SA

CIK 1841659 CHICAGO, IL

Position in GRFS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$87,381

+$85,418 QoQ

Shares Held

12,342

+5777.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#100

of 164 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DV EQUITIES, LLC holds $40,243,259 across 3 Drug Manufacturers - General names. GRFS ranks #3 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVO	Novo Nordisk A S	631,226	$30,260,974
2	GSK	GSK plc	188,762	$9,894,904
3	GRFS	Grifols SA This page	12,342	$87,381

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$87,381	12,342	+5777.1%	Shares	Other	2026-08-14
2025-12-31	$1,963	210	—	Shares	Other	2026-02-17
No filing history on record for this holder in this stock.